首页 > 文章详情

Conf. Preview | 2026 Breast Cancer Conf. on Precision Dx & Individualized Tx — Shenzhen, June

06月01日

Source：OncologyInfo

The "Breast Cancer Conference on Precise Diagnosis and Individualized Treatment and Conference on Cancer Prevention and Control in Guangdong-Hong Kong-Macao" will be grandly held in Shenzhen, China, from Thursday, June 11 to Saturday, June 13, 2026. This conference aims to build a high-level international platform for academic exchange, focusing on the latest clinical breakthroughs and cutting-edge research achievements in breast cancer. Concurrently, relevant academic activities of THE 2nd ISOPT CONGRESS will also be held, further broadening the international academic horizons of the attendees.

This year's conference is co-chaired by Professor Charles Balch, former Executive Vice President and CEO of the American Society of Clinical Oncology (ASCO); Professor William Gradishar, Chair of the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines Panel; and Professor Liao Ning from Guangdong Provincial People's Hospital. Renowned experts from home and abroad will gather to engage in high-level dialogues on the latest advances in breast cancer clinical trials through keynote speeches, roundtable discussions, and various other formats.

Comprehensive Focus & Rich Academic Insights

The conference features a compact and intensive scientific program covering the full life-cycle management of breast cancer treatment:

Frontiers in Surgery and Radiotherapy: Exploring precision approaches such as nipple-sparing mastectomy, cryosurgery applications, robotic-assisted breast surgery, and de-escalation of radiation therapy.
Breakthroughs in Systemic Therapy: Analyzing new Antibody-Drug Conjugates (ADCs) (such as China's independently developed novel HER2 ADCs), innovations in oral SERDs, and consensus controversies surrounding the PAM pathway across three major subtypes: TNBC, HER2+, and HR+.
Early-Onset and Survivorship Management: Focusing on genetic counseling for early-onset breast cancer, management of breast cancer during pregnancy, and how to build a successful breast cancer survivorship program.
Empowering Research: A special session titled "How to get your manuscript accepted by high-quality medical journals" will feature practical tips and insights shared by authoritative experts, including Professor Giuseppe Curigliano, President of the European Society for Medical Oncology (ESMO).

Gathering Global Top Authorities

The Chinese expert delegation is spearheaded by Academician He Jie and Academician Xu Ruihua. The distinguished panel of international experts includes: Professor Ricardo Audisio (Former President of the European Society of Surgical Oncology [ESSO]), Professor Charles M. Balch (Former Executive Vice President and CEO of the American Society of Clinical Oncology [ASCO]), Professor Geerard Beets (President of the European Society of Surgical Oncology [ESSO]), Professor Eduardo Cazap (Former President of the Union for International Cancer Control [UICC]), Professor Felipe Jose F. Coimbra (Secretary General of the World Federation of Surgical Oncology Societies [WFSOS]), Professor Giuseppe Curigliano (President of the European Society for Medical Oncology [ESMO]), Professor Alexander Eggermont (Former President of the European CanCer Organisation [ECCO]), Professor Michael Gnant (Co-Chair of the St. Gallen International Breast Cancer Consensus Conference), Professor William Gradishar (Chair of the National Comprehensive Cancer Network [NCCN] Breast Cancer Guidelines Panel), Professor Fred Hirsch (Former CEO of the International Association for the Study of Lung Cancer [IASLC]), and Professor V. Suzanne Klimberg (Former President of the Society of Surgical Oncology [SSO]).

Attending experts will focus on key areas such as lung cancer, breast cancer, gastrointestinal tumors, and comprehensive cancer prevention and control, systematically presenting the latest international research progress and clinical practice insights.

A Cordial Invitation to Join the Grand Event

We sincerely invite experts, scholars, and professionals engaged in breast cancer prevention, treatment, and related fields to visit Shenzhen. At this academic feast that integrates international frontiers with original Chinese research, let us jointly advance the progress of precision breast cancer treatment and bring the hope of a cure to more patients.

See you in Shenzhen in June 2026!

Professional simultaneous Chinese-English interpretation will be provided throughout the entire conference to ensure an optimal experience for all attendees.

Registration

Long-press and scan the QR code below for free registration.

报名二维码.png

Registration QR Code (Deadline: June 10, 2026)

Editor in Charge：LCM
Layout Editor：Olivia